Khai Loon Kua

CIK: 0002081556

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CYCC

Cyclacel Pharmaceuticals, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (8 total)

BGMS
Bio Green Med Solution, Inc.
Nov 5, 2025
Other(J)
Direct
467.5K shares-
BGMS
Bio Green Med Solution, Inc.
Oct 30, 2025
Sale(S)
Direct
242.5K shares at avg. $1.80$436K
BGMS
Bio Green Med Solution, Inc.
Oct 16, 2025
Sale(S)
Direct
88.2K shares at avg. $4.22$372K
BGMS
Bio Green Med Solution, Inc.
Oct 15, 2025
Sale(S)
Direct
7.5K shares at avg. $5.66$42K
BGMS
Bio Green Med Solution, Inc.
Sep 16, 2025
Sale(S)
Direct
25K shares at avg. $5.13$128K
BGMS
Bio Green Med Solution, Inc.
Sep 12, 2025
Sale(S)
Direct
22.3K shares at avg. $6.22$138K
CYCC
Cyclacel Pharmaceuticals, Inc.
Sep 5, 2025
Sale(S)
Direct
19.1K shares at avg. $7.01$134K
CYCC
Cyclacel Pharmaceuticals, Inc.
Sep 4, 2025
Other(J)
Direct
186.5K shares-

		Type	Shares	Price		Ownership
Nov 5, 2025	BGMS Bio Green Med Solution, Inc.	Other(J)	467,535	-	-	Direct
Oct 30, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	242,477	$1.80	$436,459	Direct
Oct 16, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	88,204	$4.22	$371,956	Direct
Oct 15, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	7,479	$5.66	$42,339	Direct
Sep 16, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	25,000	$5.13	$128,300	Direct
Sep 12, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	22,251	$6.22	$138,490	Direct
Sep 5, 2025	CYCC Cyclacel Pharmaceuticals, Inc.	Sale(S)	19,054	$7.01	$133,569	Direct
Sep 4, 2025	CYCC Cyclacel Pharmaceuticals, Inc.	Other(J)	186,465	-	-	Direct

1-8 of 8 transactions

About Kua Khai Loon

Kua Khai Loon (SEC CIK 0002081556) files insider reports with the SEC as 10% Owner of Cyclacel Pharmaceuticals, Inc. (CYCC).

Signal8 holds 7 ownership filings by Kua Khai Loon (1 Form 3, 6 Form 4), filed between Sep 2, 2025 and Nov 5, 2025. Those filings report 8 transactions, from Sep 4, 2025 to Nov 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Kua Khai Loon's filings is in JOHOR BAHRU, N8.

Recent filings by Kua Khai Loon

Nov 5, 2025: Other transaction of BGMS shares (Form 4, code J).
Oct 30, 2025: Open-market sale of BGMS shares (Form 4, code S).
Oct 16, 2025: Open-market sale of BGMS shares (Form 4, code S).
Oct 15, 2025: Open-market sale of BGMS shares (Form 4, code S).
Sep 16, 2025: Open-market sale of BGMS shares (Form 4, code S).

Other insiders filing for Cyclacel Pharmaceuticals, Inc. (CYCC)

Kiu Cu Seng, CFO and Secretary
Doris Wong Sing Ee, Chief Executive Officer
Yap Kim Choy, 10% Owner
Ong Yee Lung, 10% Owner
Lazar David E., Interim CEO
Tan Kok Hui, 10% Owner

How to read Form 4 transaction codes